Banks - Regional
Compare Stocks
2 / 10Stock Comparison
CARE vs UVSP
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
CARE vs UVSP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Banks - Regional |
| Market Cap | $580M | $1.10B |
| Revenue (TTM) | $255M | $518M |
| Net Income (TTM) | $31M | $91M |
| Gross Margin | 61.7% | 61.0% |
| Operating Margin | 15.7% | 21.9% |
| Forward P/E | 4.8x | 11.1x |
| Total Debt | $179M | $352M |
| Cash & Equiv. | $105M | $554M |
CARE vs UVSP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 370.7 | +270.7% |
| Univest Financial C… (UVSP) | 100 | 235.8 | +135.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs UVSP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.56
- Rev growth 6.2%, EPS growth 32.1%
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
UVSP is the clearest fit if your priority is long-term compounding and bank quality.
- 141.5% 10Y total return vs CARE's 111.1%
- NIM 2.8% vs CARE's 2.7%
- Efficiency ratio 0.4% vs CARE's 0.5% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.2% NII/revenue growth vs UVSP's 3.6% | |
| Value | Lower P/E (4.8x vs 11.1x) | |
| Quality / Margins | Efficiency ratio 0.4% vs CARE's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs UVSP's 1.01 | |
| Dividends | 2.3% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +68.4% vs UVSP's +32.7% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs CARE's 0.5% |
CARE vs UVSP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs UVSP — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
UVSP leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
UVSP is the larger business by revenue, generating $518M annually — 2.0x CARE's $255M. UVSP is the more profitable business, keeping 17.5% of every revenue dollar as net income compared to CARE's 12.3%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $255M | $518M |
| EBITDAEarnings before interest/tax | $46M | $119M |
| Net IncomeAfter-tax profit | $31M | $91M |
| Free Cash FlowCash after capex | $30M | $92M |
| Gross MarginGross profit ÷ Revenue | +61.7% | +61.0% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +21.9% |
| Net MarginNet income ÷ Revenue | +12.3% | +17.5% |
| FCF MarginFCF ÷ Revenue | +12.5% | +18.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +23.1% |
Valuation Metrics
UVSP leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, UVSP trades at a 34% valuation discount to CARE's 18.7x P/E. On an enterprise value basis, UVSP's 7.5x EV/EBITDA is more attractive than CARE's 16.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $580M | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $653M | $902M |
| Trailing P/EPrice ÷ TTM EPS | 18.69x | 12.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.76x | 11.15x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.84x |
| EV / EBITDAEnterprise value multiple | 16.33x | 7.53x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.13x |
| Price / BookPrice ÷ Book value/share | 1.40x | 1.18x |
| Price / FCFMarket cap ÷ FCF | 18.23x | 11.39x |
Profitability & Efficiency
UVSP leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
UVSP delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $8 for CARE. UVSP carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs UVSP's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +9.8% |
| ROA (TTM)Return on assets | +0.7% | +1.1% |
| ROICReturn on invested capital | +5.7% | +6.5% |
| ROCEReturn on capital employed | +1.5% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.43x | 0.37x |
| Net DebtTotal debt minus cash | $73M | -$202M |
| Cash & Equiv.Liquid assets | $105M | $554M |
| Total DebtShort + long-term debt | $179M | $352M |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.60x |
Total Returns (Dividends Reinvested)
Evenly matched — CARE and UVSP each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,800 today (with dividends reinvested), compared to $14,756 for UVSP. Over the past 12 months, CARE leads with a +68.4% total return vs UVSP's +32.7%. The 3-year compound annual growth rate (CAGR) favors UVSP at 33.5% vs CARE's 24.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +34.7% | +21.5% |
| 1-Year ReturnPast 12 months | +68.4% | +32.7% |
| 3-Year ReturnCumulative with dividends | +94.6% | +138.1% |
| 5-Year ReturnCumulative with dividends | +88.0% | +47.6% |
| 10-Year ReturnCumulative with dividends | +111.1% | +141.5% |
| CAGR (3Y)Annualised 3-year return | +24.8% | +33.5% |
Risk & Volatility
Evenly matched — CARE and UVSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than UVSP's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 1.01x |
| 52-Week HighHighest price in past year | $26.41 | $39.00 |
| 52-Week LowLowest price in past year | $15.37 | $27.91 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +99.4% |
| RSI (14)Momentum oscillator 0–100 | 75.2 | 68.5 |
| Avg Volume (50D)Average daily shares traded | 273K | 178K |
Analyst Outlook
UVSP leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CARE as "Buy" and UVSP as "Hold". Consensus price targets imply 3.2% upside for CARE (target: $27) vs -12.3% for UVSP (target: $34). UVSP is the only dividend payer here at 2.27% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $27.00 | $34.00 |
| # AnalystsCovering analysts | 4 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | +2.3% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.88 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +3.1% |
UVSP leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
CARE vs UVSP: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CARE or UVSP a better buy right now?
For growth investors, Carter Bankshares, Inc.
(CARE) is the stronger pick with 6. 2% revenue growth year-over-year, versus 3. 6% for Univest Financial Corporation (UVSP). Univest Financial Corporation (UVSP) offers the better valuation at 12. 3x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or UVSP?
On trailing P/E, Univest Financial Corporation (UVSP) is the cheapest at 12.
3x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CARE or UVSP?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +88. 0%, compared to +47. 6% for Univest Financial Corporation (UVSP). Over 10 years, the gap is even starker: UVSP returned +141. 5% versus CARE's +111. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or UVSP?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus Univest Financial Corporation's 1. 01β — meaning UVSP is approximately 80% more volatile than CARE relative to the S&P 500. On balance sheet safety, Univest Financial Corporation (UVSP) carries a lower debt/equity ratio of 37% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or UVSP?
By revenue growth (latest reported year), Carter Bankshares, Inc.
(CARE) is pulling ahead at 6. 2% versus 3. 6% for Univest Financial Corporation (UVSP). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to 22. 5% for Univest Financial Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or UVSP?
Univest Financial Corporation (UVSP) is the more profitable company, earning 17.
5% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UVSP leads at 21. 9% versus 15. 7% for CARE. At the gross margin level — before operating expenses — CARE leads at 61. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or UVSP more undervalued right now?
On forward earnings alone, Carter Bankshares, Inc.
(CARE) trades at 4. 8x forward P/E versus 11. 1x for Univest Financial Corporation — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 2% to $27. 00.
08Which pays a better dividend — CARE or UVSP?
In this comparison, UVSP (2.
3% yield) pays a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or UVSP better for a retirement portfolio?
For long-horizon retirement investors, Univest Financial Corporation (UVSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
01), 2. 3% yield, +141. 5% 10Y return). Both have compounded well over 10 years (UVSP: +141. 5%, CARE: +111. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and UVSP?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CARE is a small-cap quality compounder stock; UVSP is a small-cap deep-value stock. UVSP pays a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.